Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Function logo — Personalized functional genomics transforming the future of...

Function

Personalized functional genomics transforming the future of cancer

Founded 2019 United States San Diego, United States 7 employees Series A Total: $28.00M Biotechnology, Health and Wellness

General Information

Company Name Function
Founded Year 2019
Location United States San Diego, United States
Employees 7
Industries Biotechnology, Health and Wellness
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Function. To contact Function, visit functiononcology.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Function compare?

A PDF of Function and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Function soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Function

Function Oncology, founded in 2019 and headquartered in the United States, is revolutionizing the biotechnology and health sectors with its personalized approach to functional genomics in cancer research.

The company's slogan, "Personalized functional genomics transforming the future of cancer," encapsulates its mission to use a CRISPR-powered platform to delve deeper than traditional gene sequencing. By focusing on the function of genes, Function Oncology is poised to uncover bespoke therapeutic opportunities and spearhead the development of targeted cancer therapies.

Securing a $28.00M Series A investment on April 12, 2023, from notable investors such as Casdin Capital, Andreessen Horowitz (a16z), Alexandria Venture Investments, and Section 32, the company demonstrates strong financial backing and investor confidence.

With its innovative approach and substantial support, Function Oncology is well-positioned to drive significant advancements in precision medicine.

Business keywords: Precision Medicine, Personalized Genomics, CRISPR Technology, Functional Genomics, Cancer Research, Targeted Therapies, Gene Function Analysis, Cancer Treatment Innovation, Therapeutic Opportunities, Genomic Platform Development, Patient-Specific Treatment, Next-Generation Therapies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $28.00M 4
Casdin Capital Andreessen Horowitz/ a16z Alexandria Venture Investments
Casdin Capital, Andreessen Horowitz/ a16z +2
12 Apr 2023

Function Alternatives & Competitors

View All Alternatives
Function vs
Tango Therapeutics
Tango Therapeutics United States

Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medic...

Post-IPO Equity
182 employees
Biotechnology, Health Care
Function vs
Odimma Therapeutics
Odimma Therapeutics France

Empowering Personalized Immunotherapy to Treat Cancer

Seed
6 employees
Biotechnology, Health Care
Function vs
Chimeron Bio
Chimeron Bio United States

Redefining genetic medicine with future-forward RNA technology designed to deliver meaningful patien...

Angel
12 employees
Biotechnology, Health Care
Also compare with: Function vs TransCode Therapeutics, Inc. TransCode Therapeutics, Inc. View all alternatives

FAQ About Function

Personalized functional genomics transforming the future of cancer
Function was founded in 2019.
Function is headquartered in San Diego, United States.
Function operates in Biotechnology and Health and Wellness. Its work centres on Precision Medicine, Personalized Genomics, CRISPR Technology and Functional Genomics.
Function has approximately 7 employees.
Function has completed 1 funding round, raising a total of $28.00M. The latest funding stage is Series A.
Top alternatives and competitors to Function include Tango Therapeutics, Odimma Therapeutics, Chimeron Bio, Tavros Therapeutics, Chameleon Biosciences, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Function and Tango Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Function, https://bouncewatch.com/company/function-oncology, updated 29 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout